Checkpoint Therapeutics, Inc. (CKPT) Ownership

$4.07

north_east
$0.01 (0.25%)
Day's range
$4.05
Day's range
$4.07

Checkpoint Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
SPOTLIGHT ASSET GROUP, INC. 05/16/2023 661,597 $622,000   100.00% 5.63%
COWEN AND COMPANY, LLC 05/09/2023 220,000 $495,000   100.00% 1.87%
NEWEDGE ADVISORS, LLC 05/12/2023 26,000 $58,500   136.36% 0.22%
IRONWOOD INVESTMENT MANAGEMENT LLC 05/15/2023 16,265 $36,596   29.46% 0.14%
XTX TOPCO LTD 05/12/2023 10,125 $22,781   100.00% 0.09%
BARTLETT & CO. WEALTH MANAGEMENT LLC 02/14/2024 5,000 $11,250   0.00% 0.04%
BARTLETT & CO. LLC 04/06/2023 5,000 $11,000   0.00% 0.04%
BELPOINTE ASSET MANAGEMENT LLC 05/15/2023 85 $191   0.00% 0.00%
FORTIS CAPITAL ADVISORS, LLC 05/15/2023 52 $117   0.00% 0.00%
PARK AVENUE SECURITIES LLC 04/18/2023 0 $0   -100.00% 0.00%
ROCKEFELLER CAPITAL MANAGEMENT L.P. 05/16/2023 0 $0   -100.00% 0.00%
TRADITION WEALTH MANAGEMENT, LLC 05/12/2023 0 $0   -100.00% 0.00%

Checkpoint Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 31 institutional investors and hedge funds held shares of Checkpoint Therapeutics, Inc.. The most heavily invested institutionals were:

Kestra Advisory Services, LLC: 329,281

BlackRock Funding, Inc. /DE: 285,252

Gladstone Institutional Advisory LLC: 61,399

PARK AVENUE SECURITIES LLC: 59,915

Walleye Capital LLC: 44,500

180 WEALTH ADVISORS, LLC: 44,300

5.63% of Checkpoint Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 3.08 M shares in the last 24 months. This purchase volume represents approximately $12.52 M in transactions.